The KeyBank Foundation has awarded Stark State and ArtsInStark with grant funds to further their missions of bettering the Canton community and surrounding area.
At Chemours, we strive to make chemistry as responsible as it is essential. Our products play a critical role in our daily lives, the global economy, and a better future for our world.
Our Board is currently comprised of eleven members, each of whom has a term expiring at the Company’s 2024 annual general meeting of shareholders.
We have developed and now manufacture and commercialize proprietary medicines for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder - disease areas with vulnerable patient populations who are often treated in public health.